KPC Pharmaceuticals Inc Cash Flow-to-Debt Ratio
KPC Pharmaceuticals Inc cash flow-to-debt ratio. KPC Pharmaceuticals Inc (600422) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of CN¥113.07 Million could theoretically repay 0% of its total liabilities (CN¥4.83 Billion) in one year. Check 600422 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of KPC Pharmaceuticals Inc (1999–2025)
Cash flow-to-debt ratio of KPC Pharmaceuticals Inc from 1999 to 2025. Historical debt coverage capacity for KPC Pharmaceuticals Inc across 27 annual periods. Check KPC Pharmaceuticals Inc (600422) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
KPC Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (1999–2025)
KPC Pharmaceuticals Inc cash flow-to-debt ratio by year from 1999 to 2025. Year-by-year debt coverage analysis for KPC Pharmaceuticals Inc. For the full cash flow conversion analysis, see KPC Pharmaceuticals Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | CN¥289.24 Million | CN¥4.83 Billion | ▼ -56.6% |
| 2024 | 0.14x | CN¥808.07 Million | CN¥5.87 Billion | ▼ -20.7% |
| 2023 | 0.17x | CN¥754.33 Million | CN¥4.34 Billion | ▲ +193.6% |
| 2022 | 0.06x | CN¥253.90 Million | CN¥4.29 Billion | ▼ -7.0% |
| 2021 | 0.06x | CN¥251.63 Million | CN¥3.95 Billion | ▼ -45.3% |
| 2020 | 0.12x | CN¥409.94 Million | CN¥3.52 Billion | ▼ -15.9% |
| 2019 | 0.14x | CN¥429.50 Million | CN¥3.10 Billion | ▲ +15.8% |
| 2018 | 0.12x | CN¥352.07 Million | CN¥2.94 Billion | ▲ +26.5% |
| 2017 | 0.09x | CN¥242.53 Million | CN¥2.56 Billion | ▼ -45.6% |
| 2016 | 0.17x | CN¥311.16 Million | CN¥1.79 Billion | ▼ -41.2% |
| 2015 | 0.30x | CN¥476.62 Million | CN¥1.61 Billion | ▼ -24.0% |
| 2014 | 0.39x | CN¥379.13 Million | CN¥974.40 Million | ▲ +61.9% |
| 2013 | 0.24x | CN¥241.97 Million | CN¥1.01 Billion | ▲ +23.4% |
| 2012 | 0.19x | CN¥213.33 Million | CN¥1.10 Billion | ▼ -1.0% |
| 2011 | 0.20x | CN¥140.24 Million | CN¥712.37 Million | ▲ +29.2% |
| 2010 | 0.15x | CN¥90.82 Million | CN¥595.84 Million | ▼ -40.0% |
| 2009 | 0.25x | CN¥128.57 Million | CN¥505.79 Million | ▲ +35.0% |
| 2008 | 0.19x | CN¥91.59 Million | CN¥486.48 Million | ▼ -19.7% |
| 2007 | 0.23x | CN¥130.06 Million | CN¥554.98 Million | ▲ +108.3% |
| 2006 | 0.11x | CN¥61.25 Million | CN¥544.44 Million | ▲ +141.9% |
| 2005 | -0.27x | CN¥-174.52 Million | CN¥650.31 Million | ▼ -4235.1% |
| 2004 | -0.01x | CN¥-2.78 Million | CN¥448.75 Million | ▼ -102.9% |
| 2003 | 0.21x | CN¥61.23 Million | CN¥286.76 Million | ▲ +136.0% |
| 2002 | 0.09x | CN¥17.38 Million | CN¥192.11 Million | ▼ -72.4% |
| 2001 | 0.33x | CN¥67.07 Million | CN¥204.24 Million | ▲ +65.8% |
| 2000 | 0.20x | CN¥47.76 Million | CN¥241.15 Million | ▼ -3.3% |
| 1999 | 0.20x | CN¥60.24 Million | CN¥294.19 Million | — |